Comparing Clinical Application of Innovatedly Made Transpalatal Arch (TPA) From 3D Reconstructed Model and Conventionally Made TPA
Launched by UNIVERSITY OF MALAYA · Nov 24, 2018
Trial Information
Current as of June 02, 2025
Unknown status
Keywords
ClinConnect Summary
INTRODUCTION
Transpalatal Arch (TPA) has been invented by Dr. Robert Ara Goshgarian, a renowned orthodontist more than 7 decades ago. Throughout the years, various modifications of the design were made for different purposes and to increase its efficacy in achieving the optimum level of anchorage. In 1947, fabrication of Nance Palatal Ach (NPA) pioneered the adjustment of TPA by incorporation of an acrylic button that connects the palatal wire at the highest part of palatal vault. Recent innovations mostly involved adhesions of TPA to mini implants or temporary anchorage devices (TAD) and ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18 and above
- • 2. Requiring premolar extractions
- • 3. Patients do not have previous orthodontic treatment before
- Exclusion Criteria:
- • 1. Patient requiring lingual arch, modified TPA, Nance Palatal ArchNon extraction upper arch treatment
- • 2. Patients requiring upper arch expansion
- • 3. Requiring upper first permanent molar extraction
- • 4. Presence of dento-facial anomalies.
- • 5. Patients requiring orthognathic surgery
About University Of Malaya
The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, , Malaysia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials